(Q63844693)
Statements
INSPIRE (English)
0 references
A Phase II Baseline Versus Treatment Study to Determine the Efficacy of Raltegravir (Isentress) in Preventing Progression of Relapsing Remitting Multiple Sclerosis as Determined by Gadolinium-enhanced MRI (English)
0 references
April 2013
0 references
September 2014
0 references
23
0 references
18 year
0 references
55 year
0 references